Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815509) titled 'Finerenone for Premature Ovarian Insufficiency (POI)' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: The University of Hong Kong-Shenzhen Hospital

Condition: Premature Ovarian Insufficiency

Intervention: Drug: Finerenone

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: September 15, 2026

Target Sample Size: 46

Countries of Recruitment: China

To know more, visit https://clinicaltr...